Press
·
News
P+P advised Dermapharm Holding SE on acquisition of Merck subsidiary Allergopharma
The transaction is still subject to the approval of the relevant regulatory authorities; the transaction is expected to close at the end of the second quarter 2020.
Dermapharm Holding SE is headquartered in Grünwald and focuses on the manufacture and distribution of high-quality dermatological and allergological pharmaceutical products. Allergopharma specializes in desensitization for allergies.
P+P Pöllath + Partners advised Dermapharm Holding SE on all legal matters related to the acquisition with the following team that specializes in various practice areas across all offices:
- Dr. Matthias Bruse (partner, lead, corporate/M&A, Munich)
- Daniel Wiedmann (associated partner, antitrust law, Frankfurt)
- Dr. Matthias Werner (counsel, real estate, Berlin)
- Christine Funk (senior associate, IP/M&A, Frankfurt)
- Jasmin Wagner (senior associate, corporate/M&A, Munich)
- Dr. Jesko von Mirbach (associate, corporate/M&A, Berlin)
- Dr. Lena Hummel (associate, corporate/M&A, Munich)
